Application of a High Throughput Method of Biomarker Discovery to Improvement of the EarlyCDT^®-Lung Test

• Isabel K. Macdonald ,

  * E-mail: Isabel.Macdonald@nottingham.ac.uk

  Affiliation Oncimmune Ltd, Nottingham City Hospital, Nottingham, United Kingdom

  ⨯
• Andrea Murray,

  Affiliation Oncimmune Ltd, Nottingham City Hospital, Nottingham, United Kingdom

  ⨯
• Graham F. Healey,

  Affiliation Oncimmune Ltd, Nottingham City Hospital, Nottingham, United Kingdom

  ⨯
• Celine B. Parsy-Kowalska,

  Affiliation Oncimmune Ltd, Nottingham City Hospital, Nottingham, United Kingdom

  ⨯
• Jared Allen,

  Affiliation Oncimmune Ltd, Nottingham City Hospital, Nottingham, United Kingdom

  ⨯
• Jane McElveen,

  Affiliation Oncimmune Ltd, Nottingham City Hospital, Nottingham, United Kingdom

  ⨯
• Chris Robertson,

  Affiliation Department of Mathematics and Statistics, University of Strathclyde, Glasgow, United Kingdom

  ⨯
• Herbert F. Sewell,

  Affiliations Oncimmune Ltd, Nottingham City Hospital, Nottingham, United Kingdom, Centre of Excellence for Autoimmunity in Cancer, University of Nottingham, Nottingham, United Kingdom

  ⨯
• Caroline J. Chapman,

  Affiliations Oncimmune Ltd, Nottingham City Hospital, Nottingham, United Kingdom, Centre of Excellence for Autoimmunity in Cancer, University of Nottingham, Nottingham, United Kingdom

  ⨯
• John F. R. Robertson

  Affiliations Oncimmune Ltd, Nottingham City Hospital, Nottingham, United Kingdom, Centre of Excellence for Autoimmunity in Cancer, University of Nottingham, Nottingham, United Kingdom

  ⨯